Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07QIT
|
||||
| Former ID |
DIB003571
|
||||
| Drug Name |
GPX-150D
|
||||
| Synonyms |
CNDO-101; CNDO-101); GPX-150; Doxorubicin analog (cancer), Coronado; 5-imino-13-deoxy-doxorubicin
|
||||
| Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Phase 2 | [524956] | ||
| Company |
Gem Pharmaceuticals LLC
|
||||
| Canonical SMILES |
c12c([C@H](C[C@@](C2)(CCO)O)O[C@H]2C[C@@H]([C@@H]([C@@H<br />](O2)C)O)N)c(c2c(c1O)C(=O)c1c(C2=N)c(ccc1)OC)O
|
||||
| CAS Number |
CAS 236095-26-4
|
||||
| Target and Pathway | |||||
| Target(s) | DNA topoisomerase II | Target Info | Modulator | ||
| References | |||||